不寐一號方治療腦梗死后肝郁脾虛型睡眠障礙臨床療效觀察

打開文本圖片集

Observation on the Clinical Efficacy of Bu Mei No.1 Prescription in Treating Sleep Disorders ofLiver Depression and Spleen Deficiency Type after Cerebral Infarction

LI Na

（Zibo Linzi Traditional Chinese Medicine Hospital，Zibo 2554Oo，China）

AbstractObjective：Toanalyze the mechanismof liver depressionand splee deficiencytypeslee disorders in patientsafter cerebralifarctiondevaluatetheectivenesoftheBueiNo.1prescriptin.Methods：Atotalof7pantsithlepisordersofliverdepressonandspleedeficiencytypeaftercerebralinfarctionadmitedtothZiboLinziTraditionalChineseMedicine Hospital fromJune2O23to June2O24wereselectedastheresearch subjects.Theywererandomlydividedintoacontrol groupandanobservationgroup，with36casesineach group，acording totherandomnumber table method.Thediferences in sleepqualitybetweentwogroupsofpatients werecomparedusing the Pitsburgh SleepQualityIndex（PSQI）.Thetreatmentoutcomesof thetwo groupswerecompared.Results：After intervention，thePSQIscoresof theobservation groupweresignificantly lowerthanthoseofthecontrolgroup，andthetreatmentefectivenessrateoftheobservationgroupwassignificantlyhigherthan that of the control group. The diferences between the two groups were statistically significant（ P<0.05 ）. Conclusion： The therapeutic ffectsofBuMeiNo.1prescription hasbeenunanimouslyrecognized，andithasasignificantaleviatingand mproving efectsonsleedisordersofliverdepressionandsplendeficiencytypeinpatients withcerebralinfarction，makingitsuitablefor clinical treatment.

KeywordsCerebralinfarction;Liverdepressionand spleendeficiencytype;Sleepdisorders；BuMeiNo.1prescription;Traditional Chinese medicine； Integrated Traditional Chinese and Western Medicine; Sleep quality； Life quality 中圖分類號：R722. 15+1 ;R338. 63 文獻(xiàn)標(biāo)識碼：A doi：10.3969/j. issn.2095 -7130.2025.02.034

腦梗死是我國居民疾病致死因素中的常見病，以多并發(fā)癥為特點(diǎn)，其中睡眠障礙問題尤為顯著。（剩余4187字）